Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/d41586-021-01246-x | DOI Listing |
Int J Surg
December 2024
Department of Chemistry, Faculty of Science, Al-Azhar University, Nasr City, Cairo, Egypt.
The potential of biomaterials in medical sciences has attracted much interest, especially in promoting tissue regeneration and controlling immune responses. As the COVID-19 pandemic broke out, there was an increased interest in understanding more about how biomaterials could be employed to fight this dreaded disease, especially in the context of regenerative medicine. Out of the numerous regenerative medicine possibilities, stem cells and scaffolding (grafting) technology are two major areas in modern medicine and surgery.
View Article and Find Full Text PDFCoronavirus disease (COVID-19), which broke out in China and caused a devastating pandemic worldwide, is associated with a significantly increased risk of thrombotic complications, especially pulmonary embolism. During the COVID-19 pandemic, investigations have reported a high incidence of venous thromboembolic (VTE) events in hospitalized patients with COVID-19, often despite thromboprophylaxis. Current recommendations for thromboprophylaxis are based on randomized clinical trials, which usually exclude patients at а potentially high risk of hemorrhagic complications.
View Article and Find Full Text PDFClin Psychol Eur
March 2024
Department of Psychology, Stockholm University, Stockholm, Sweden.
BMC Pulm Med
July 2024
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, National Medical Center for Infectious Diseases, Zhejiang University School of Medicine, Hangzhou, China.
Background: The Omicron variant broke out in China at the end of 2022, causing a considerable number of severe cases and even deaths. The study aimed to identify risk factors for death in patients hospitalized with SARS-CoV-2 Omicron infection and to establish a scoring system for predicting mortality.
Methods: 1817 patients were enrolled at eight hospitals in China from December 2022 to May 2023, including 815 patients in the training group and 1002 patients in the validation group.
J Neuroophthalmol
September 2024
Department of Ophthalmology (S-CY), Tainan Hospital, Ministry of Health and Welfare, Tainan, Taiwan; Department of Ophthalmology (S-CY, Y-KL, H-WH, Y-SC), and Department of Medical Imaging (M-TC), National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Institute of Clinical Medicine (S-CY), College of Medicine, National Cheng Kung University, Tainan, Taiwan; Department of Exercise Science (H-YC), College of Science, Delta State University, Cleveland, Mississippi; and Department of Ophthalmology (Y-SC), College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Background: The coronavirus disease (COVID-19) pandemic broke out in March 2020, causing tremendous damage to public health and more than 6 million deaths. After authorization for the emergency use of COVID-19 vaccines, various adverse events have been reported, including optic neuritis. COVID-19 vaccination was implemented in Taiwan in March 2021.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!